Talk:Anti-transglutaminase antibodies
From Wikipedia, the free encyclopedia
 |
This article is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at the doctor's mess. |
| B | This page has been rated as B-Class on the quality assessment scale |
| Mid | This article has been rated as Mid-importance on the importance assessment scale |
[edit] Calcium, Zinc and ATA
Eur J Intern Med. 2008 Mar;19(2):83-91. Transglutaminase and the pathogenesis of coeliac disease. Stenberg P, Roth EB, Sjöberg K.
"....With its focus on TG2, this review highlights some of the intriguing mechanisms of the pathogenesis of coeliac disease, such as the structure of the neo-antigen, the involvement of calcium and zinc, and the effects of coeliac antibodies on TG2 activity. Moreover, the many pitfalls due to dubious laboratory practice are addressed, as is the potential when a fundamental biological mechanism is understood at the molecular level...." —Preceding unsigned comment added by Pdeitiker (talk • contribs) 00:55, 16 February 2008 (UTC)
[edit] Association with multiple myeloma
BMC Immunol. 2008 May 28;9:22. Humoral immunoreactivity to gliadin and to tissue transglutaminase is present in some patients with multiple myeloma.Juranic Z, Radic J, Konic-Ristic A, Jelic S, Mihaljevic B, Stankovic I, Matkovic S, Besu I, Gavrilović D.
"Statistical analysis of data obtained revealed that only the levels of anti-tTG-2 IgA immunoreactivity in patients with MM were significantly higher than these obtained in healthy controls (P < 0.02) CONCLUSION: Data obtained showed the existence of the enhanced serum immunoreactivity to gliadin, tTG-2 and Ro/SSA antigens in some patients with MM. These at least partially could contribute to the immunological imbalance frequently found in this disease."
